Sign In
Buy BLU
$14.74
+0 (+0%)
At Close: Sep 27, 2023
'Diamond-handed HODLers' of GameStop and AMC take a Monday pummeling from the soft-handed crowd
12:31am, Tuesday, 14'th Dec 2021 MarketWatch
As the market sells off amidst growing omicron and inflation fears, meme stocks get crushed despite the "Apes" staying strong.
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
09:01pm, Monday, 13'th Dec 2021 Kwhen Finance
Here's Why Bellus Health Is Jumping Higher Today
04:19pm, Monday, 13'th Dec 2021 The Motley Fool
A phase 2 trial with the company's chronic-cough candidate hit its primary endpoint.
Biotech Penny Stocks To Buy After BLU Stock Explodes? 3 To Watch
03:22pm, Monday, 13'th Dec 2021 PennyStocks
3 biotech penny stocks to watch after Bellus Health (BLU) skyrockets.
The post Biotech Penny Stocks To Buy After BLU Stock Explodes? 3 To Watch appeared first on Penny Stocks to Buy, Picks, News and I
NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today
11:13am, Monday, 13'th Dec 2021
Nuverra Environmental (NES) stock is surging higher on Monday following news of a massive deal with Select Energy Services (WTTR). The post NES, WTTR: The Deal That Has Penny Stock Nuverra Environment
BLU Stock Alert: The Study Data That Has BELLUS Health Blasting Higher Today
10:55am, Monday, 13'th Dec 2021
BELLUS Health (BLU) stock is rocketing higher on Monday and it's all thanks to data from a Phase 2b clinical trial of BLU-5937. The post BLU Stock Alert: The Study Data That Has BELLUS Health Blasting
Pharma Stock Hits Annual High on Study Results
10:50am, Monday, 13'th Dec 2021
The shares of Bellus Health Inc (NASDAQ:BLU) are soaring today, up 63% to trade at $9.13 at last check, after the Canada-based drug name announced positive results from a mid-stage study of its cough
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
01:17pm, Tuesday, 07'th Dec 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome
Acadia Pharmaceuticals Inc. (N
Is the Options Market Predicting a Spike in BELLUS Health (BLU) Stock?
02:04pm, Friday, 26'th Nov 2021 Zacks Investment Research
Investors need to pay close attention to BELLUS Health (BLU) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in BELLUS Health (BLU) Stock?
10:43am, Friday, 26'th Nov 2021
Investors need to pay close attention to BELLUS Health (BLU) stock based on the movements in the options market lately.
Bellus Health (BLU) Reports Q3 Loss
07:50pm, Wednesday, 10'th Nov 2021
Bellus (BLU) delivered earnings and revenue surprises of -20.83% and 0.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
09:25am, Thursday, 14'th Oct 2021
With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market. The post 7 Biotech Penny Stocks With Huge Catalysts Coming in 2022 ap
3 Biotech Stocks That Surged in September
07:39am, Tuesday, 05'th Oct 2021
Find out why last month was a big one for these three drugmakers.
BELLUS (BLU) Completes Enrollment in Two Mid-Stage Studies
10:45am, Friday, 24'th Sep 2021
BELLUS (BLU) completes enrollment in the mid-stage studies for refractory chronic cough and chronic pruritus associated with atopic dermatitis.
Implied Volatility Surging for BELLUS Health (BLU) Stock Options
12:14pm, Wednesday, 15'th Sep 2021
Investors need to pay close attention to BELLUS Health (BLU) stock based on the movements in the options market lately.
